Abstract--stChromium-labeled rat pulmonary artery endothelial cells (EC) cultivated in MEM medium were killed, in a synergistic manner, by mixtures of subtoxic amounts of glucose oxidase-generated H202 and subtoxic amounts of the following agents: the cationic substances, nuclear histone, defensins, lysozyme, poly-L-arginine, spermine, pancreatic ribonuclease, polymyxin B, chlorhexidine, cetyltrimethyl ammonium bromide, as well as by the membrane-damaging agents phospholipases A2 (PLA2) and C (PLC), lysolecithin (LL), and by streptolysin S (SLS) of group A streptococci. Cytotoxicity induced by such mixtures was further enhanced by subtoxic amounts either of trypsin or of elastase. Glucose-oxidase cationized by complexing to poly-L-histidine proved an excellent deliverer of membrane-directed H202 capable of enhancing EC killing by other agonists. EC treated with rabbit anti-streptococcal IgG were also killed, in a synergistic manner, by H202, suggesting the presence in the IgG preparation of c ross-reactive antibodies. Killing of EC by the various mixtures of agonists was strongly inhibited by scavengers of hydrogen peroxide (catalase, dimethylthiourea, MnCI2), by soybean trypsin inhibitor, by polyanions, as well as by putative inhibitors of phospholipases. Strong inhibition of cell killing was also observed with tannic acid and by extracts of tea, but less so by serum. hand, neither deferoxamine, HCIO, TNF, nor GTP3,S had any modulating effects on the synergistic cell killing. EC exposed either to 6-deoxyglucose, puromycin, or triftupromazin became highly susceptible to killing by mixtures of hydrogen peroxide with several of the membrane-damaging agents. While maximal synergistic EC killing was achieved by mixtures of H202 with either PLA> PLC, LL, or with SLS, a very substantial release of [3H]amchidonic acid (AA), PGE2, and 6-keto-PGF occurred only if a proteinase was also added to the mixture of agonists. The release of AA from EC was markedly inhibited either by scavengers of H202, by proteinase inhibitors, by cationic agents,by HC10, by tannic acid, and by quinacrin. We suggest that cellular injury induced in inflammatory and infectious sites might be the result of synergistic effects among leukocyte-derived oxidants, lysosomal hydrolases, cytotoxic cationic polypeptides, pmteinases, and microbial toxins, which might be present in exudates. These "cocktails" not only kill cells, but also solubilize AA and several of its metabolites. However, AA release by the various agonists can be also achieved following attack by leukocyte-derived agonists on dead cells. It is proposed that treatment by "cocktails" of adequate antagonists might be beneficial to protect against cellular injury in vivo.
INTRODUCTION
The mechanisms by which microbial products, complement components, activated neutrophils, and macrophages injure and kill mammalian cells in infectious and inflammatory sites has been the focus of intensive investigations in the last decade (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . The idea that target cell killing by some of these agents might be the result of "multiple synergistic hits" induced by the combined action of microbial hemolysins, antibodies, complement components, and proteinases came from our earlier studies with both normal and malignant cells (14) (15) (16) . We have recently also investigated the synergistic killing effects of combinations among hydrogen peroxide (H202), cationic polyelectrolytes, phospholipases A2 and C, a streptococcal hemolysin, and lipoteichoic acid on a variety of cells in culture (17) (18) (19) (20) (21) . Our working hypothesis (21) is that sublethal injuries induced in mammalian cells by membrane-damaging agents might be greatly amplified by exposure to oxidants and to proteinases.
The present model further expands our previous observations (17) (18) (19) (20) (21) and describes the killing of endothelial cells (EC) in culture and the parallel release of arachidonic acid and some of its metabolites from cells treated by combinations of oxidants, phospholipases, cationic agents, a streptococcal hemolysin, and proteinases. These agents were chosen because they represent products that are likely to be present in inflammatory and infectious sites. To further study the possible mechanisms by which these simulated leukocyte-and bacterialderived "cocktails" of agonists kill EC and also degrade their membrane lipids, a variety of modulating agents (antioxidants, polyanions, proteinase inhibitors, putative inhibitors of phospholipases, antimetabolites) were tested. The possible relevance of this in vitro tissue culture model to the events that occur when activated leukocytes induce cell and tissue injury in inflammation will be briefly discussed.
MATERIALS AND METHODS

Endothelial Cells (EC)
Rat pulmonary artery endothelial cells (EC) were obtained according to the procedure of Jaffe (22) and Ryan and White (23', , employing a minimal essential medium of Eagle with Earl's salts (MEM) supplemented with glu:amine, penicillin, and streptomycin as described in detail (17) . Upon isolation, the cells exhibited the typical cobblestone morphology of endothelial cells. The cell monolayers were grown in 24-well plates at 37~ with 5% CO2. All experiments were conducted on cells passaged less than 34 times since isolation.
Labeling of EC with Ck, romium 51 . Trypsinized endothelial cells were suspended in MEM medium supplemented with 10% FCS containing 1 #Ci/ml of [5~Cr]NaCrO4. The cells were then seeded into 24-well dishes (1 ml/well). Following incubation for 24-36 h confluent monolayers were obtained. These were washed three times in serum-free MEM medium to remove unbound radioactivity. One milliliter of serum-free medium was then added to each well and the plates were then used for cytotoxicity assays (see below).
Labeling of EC with [3H]Arachidonic Acid (AA).
Trypsinized endothelial ceils were suspended in MEM medium supplemented with 10% FCS and 20 t~l of [3H]amchidonic acid (76.0 Ci/ mmol) per 100 ml of cell suspension was then added. The ceils were seeded into 24-well plates and grown to confluency.
Cationization of Glucose Oxidase (GO) and Catalase
Solutions containing either 1 mg/ml of GO (100 units/ml) or 1 mg/ml of catalase (100,000 units/mg) were rendered cationic by complexing with 1 mg/ml of poly-u-histidine HC1 (tool wt 23,000) (PHSTD) (24) . Brieffr 1 ml of the enzymes was mixed with 1 mg/ml of PHSTD in saline, pH 6.0. The mixtures were incubated for 5 min at room temperature to allow complex formation, This was followed by the addition of 5 vol of saline buffered with 3 mM HEPES buffer, pH 7.4, The opalescent solution that developed was centrifuged for 5 min at 2000 rpm, and the precipitate was resuspended in 1 ml saline. Such cationized enzymes retained greater than 95 % of their original activities as determined by their ability either to generate hydrogen peroxide in the presence of glucose or to destroy its activity (24) . The cationized enzymes avidly bound to endothelial cells (see below).
Cytotoxicity Assay
Cytotoxicity induced by the various agonists was determined by the chromium release method described in detail (17, 18) . A:; the end of the incubation period specified in the different experiments, the cultures were monitored ngicroscopically for altered cell morphology. The amounts of chromium solubilized from the cells were determined following centrifugation of the culture supemates or 5 min at 2000 rpm in a refrigerated centrifuge. Total radioactivity associated with the cells was determined after lysing control monolayers with 1 ml of 1% Triton X-100. In all experiments, the amount of radioactivity released in response to treatment was compared with the amounts released in cultures incubated with medium alone (spontaneous release). Radioactivity measurements were performed in a gamma counter. The release of [3H]AA was determined in a scintillation counter employing Scintiverse BD (Fisher) as a scintillation fluid, and the results were calculated as percentage release of radioactivity compared to the total release obtained by treating control wells by Triton X-100. It should be noted that the release of more than 40% of the total chromium label from EC usually resulted in a near total inhibition of cell replication upon transfer to fresh medium (10, 17) .
Measurement of Cyclooxygenase and Lipoxygenase Products
Supematant fluids obtained from wells treated by the various agents were tested for the content of PGE2, 6-keto-PGF, and thromboxane B2 by radioimmunoassay performed by the University of Michigan Ligand Core Laboratory and detailed in the publication of Spore et al. (25) . Sensitivities of the assays were 0.5 pg/100 #1 of supemate for thromboxane B 2 and 2 pg/100 tzl for PGE 2 and 6-keto-PGF.
Agents Employed to Kill Cells and Release AA and Its Metabolites
Hydrogen Peroxide (H202). One milliliter of MEM medium (containing 1 mg/ml of glucose) was incubated with 0.2 units/ml of glucose oxidase (100,000 units/g), resulting in the generation of approximately 1 mM of H202 after 15 min. Because of glucose limitation, the amounts of peroxide generated remained nearly the same even after 2 h of incubation. This amount of GO-generated peroxide did not induce the release of any significant amounts of chromium. The method of Thunnan et al. (26) was used to quantify the peroxide.
The following agents were employed to synergize with H202 to kill EC: (A) phospholipase A 2 from bee venom (0.1-25 units/ml); (B) lysophosphatidylcboline (lysolecithin, LL) (1-30 /zg/ ml); (C) phospholipase C from Clostridium welehii (0.01-0.15 units/ml); (D) streptolysin S (SLS) from group A streptococci (1000 units/ml) (27) ; (E) lipoteichoic acid (LTA) from group A streptococci (1-100/zg/ml) (19); (F) rabbit anti-streptococcal IgG possessing 39,000 agglutinating units/ mg as assayed by passive hemagglutination of human red blood coated by LTA (19) ; (G) crystalline trypsin (10,000-13,000 BAEE units/mg) and pancreatic porcine elastase (40-80 units/mg protein); (H) crystalline egg-white lysozyme (56,000 units/mg) and milk lysozyme (100,000-200,000 units/ mg); (I) cationic agents nuclear histone (type II-A), poly-L-arginine HC1 (PARG) (mol wt 40,000), porcine pancreatic ribonuclease, polymyxin B, chlorhexidine gluconate, cetyltrimethyl ammonium bromide (CETAB), spermine, histamine HC1, defensins NP-1 and NP-5 (kindly donated by Dr. M. Friedkin from the Weitzman Institute, Rehovot, Israel); (J) hypochlorous acid (HC10), generated by the addition of sodium hypochlorite to distilled water at pH 6.0; (K) tumor necrosis factor (TNF) (form Genetec); (L) soybean trypsin inhibitor (SBTI).
The following agents were employed to modulate the killing of EC: catalase, dimethylthiourea (DMTU), deferoxamine mesylate, 6-deoxyglucose, pummycin, triflupromazine (TFP), guanosine 5-O-(3-thiotriphosphate) (GTP3'S), tannic acid, extracts of tea, quinacrine heparin, polyanthole sulfonate, and MnCI2. Most of the agents were purchased from Sigma Chemical Co., St. Louis, Missouri. Elastase was from Worthington Biochemical Corporation, Freehold, New Jersey. MnC12-4H20 was from Mallin~:krodt Chemical Works, St. Louis, Missouri.
RESULTS
Cell Killing
Combined Effect of Cationic Agents and He02 on EC. Bactericidal cationic agents are present in large amounts in granules of PMNs (leukocyte cationic proteins, defensins, myeloperoxidase, lysozyme), in eosinophils (major cationic proteins), in platelets, in plasma, (/3-1ysins), in saliva (histidine-rich proteins), in tears, and in milk (lysozyme) as well as in semen (spermine, spermidine) (reviewed in 28). Furthe~maore, large amounts of histones might also be present in inflamed sites as a re,;ult of cell death. The likelihood that membrane-damaging cationic agents (4, 6, 28) might collaborate with oxidants to kill EC was further investigated (see 17) .
In a representative 2-h assay, Figures 1 and 2 show the time-course and dose-dependent release of chromium, respectively, from monolayers of EC treated with different cationic agents combined with GO-generated H202. The data suggest that subtoxic concentrations of most of the agents synergized with subtoxic concentrations of H202 kill the cells (17, 21) . Under similar experimental conditions only high concentrations either of egg-white or milk lysozyme (1 mg protein/ml) showed low-level, but significant synergy with H202 (not To determine whether or not the simultaneous presence of both H202 and the cationic agents was necessary to induce cell damage, the following experiments were performed: Cell monolayers were preincubated for 45 min either with histone or with GO. The monolayers were then washed to remove unbound agent and either GO or histone was then added. Table 1 shows that cells exposed to histone and then washed were still damaged upon addition of GO. No such phenomenon occurred, however, when the cells were first exposed to GO, washed, and then challenged with histone, suggesting that only histone avidly bound to the targets and then synergized with H202 to kill the cells. These results suggest that both peroxide and histone must be present simultaneously in order to exert a synergistic toxic effect on the cells. The presence of either catalase (100 units/ml but not heat-inactivated catalase), DMTU (100/zM) or Mn 2+ (1 mM) (29) during the incubation period totally inhibited cytotoxicity. It was also found that EC that had been precoated either by PHSTD-catalase complex (24) or by catalase cationized by the method of Dannon et al. (30) and washed were totally refractory to the synergistic toxic effect of added GO + histone (see ref. 24) .
Effect of Cationized GO on EC Killing. The synergistic killing induced by combinations of cationic agents with hydrogen peroxide also led us to explore the possibility that an enhancement of peroxide delivery to cell surfaces might serve as a tool to enhance cell killing. For this purpose GO was complexed to PHSTD by the same method employed to cationize catalase (24) . Table 2 shows that cells pretreated with cationized GO and then washed were readily killed upon the addition of histone suggesting that cationization allowed GO to adhere to the cell surfaces and to deliver H202 directly to them. To prove that cationized GO might also be effective as a tissue-damaging agent in vivo, we instilled GO-PHSTD complexes into Lhe trachea of anesthetized rats. In preliminary experi- aMonolayers of EC were preincubated for 45 rain at 37~ either with MEM alone, GO (which yielded approximately 750 nrnol H202 after 45 min of incubation), or histone. Some of the wells were washed to remove unbound agent. This was immediately followed by the addition either of medium, GO, or histone. Following an additional 1 h of incubation, the supernatant fluids were removed and the radioactivi:y solubilized was determined. The data are the average of three experiments. aEC monolayers were incubw:ed for 45 min at 37~ either with GO or with GO that had been complexed with poly-L-histidine (PHSTD) (Materials and Methods). The monolayers were either left intact or washed to remove unbound agent. This was immediately followed by the addition either of medium or medium + histone. Sixty minutes later the release of soluble radioactivity was determined in the supernatant fluids. The data represent averages of three different experiments.
ments (to be published in detail), we found that cationized GO was at least 10-fold more toxic to the lung than regular GO. This was determined by measuring the index of injury following the leakage into the lungs of systemically administered iodine-labeled BSA. Such enhanced lung injury could, however, be totally inhibited by administering a mixture of glycine and MnC12 (see ref. 29) , which scavenged H202.
Combined Effects of Cationic Agents, 1-1202, and Proteinases on EC.
Previous studies from our laboratory have described the synergistic killing of EC by combinations between proteinases and H202 (18) and between certain membrane-active agents and H202 (17, 21) . It was therefore also of interest to test the combined effect of membrane-active agents, H202, and a proteinase on EC.
As a model, either trypsin or pancreatic elastase were used as representative proteinases, CETAB as a cationic agent (because of its resistance to protease activity) (see below), and GO as a generator of H202. Figure 3 shows that trypsin strongly synergized with GO and with subtoxic concentrations of CETAB to release large amounts of the chromium label from the targets. Similar results were obtained with elastase (not shown). Thus a triple synergy is more efficient than a double synergy in cell killing. The killing effect due to the triple synergy was markedly inhibited either by catalase, Mn 2+, heparin, or SBTI (not shown). Experiments with histone, however, gave inconsistent results as this cationic agent was hydrolyzed by trypsin. To circumvent this problem, we first preincubated EC with histone to allow binding and "priming" of the cells (see Table  1 ) and then added GO and trypsin. We found that histone binding primed the CETAB gg/ml Fig. 3 . The combined effects of CETAB hydrogen peroxide and trypsin on endothelial cells. Endothelial cells were exposed for 90 rain at 37~ to increasing concentrations of CETAB, to fixed amounts of GO (0.2 units/ml), or trypsin (100 ~g/ml), to combinations of CETAB, GO, and trypsin and to GO and trypsin. A representation of a typical experiment.
cells to cytotoxicity following the addition of GO, but no significant further enhancement of cell killing occurred upon addition of trypsin, suggesting that the protease might have hydrolyzed the cell-bound histone.
Combined Effect of 11202, PLC, Lysolecithin, and Trypsin on EC.
Inflammatory sites mighl be rich in exocytosed lysosmal products of leukocytes. Thus, target ceils might either become simultaneously or sequentially exposed to a multiplicity of hydrolases, cationic proteins, and oxidants (17, 18, 21) . It was of interest to test wlcLether, as in the case of histone, other agents might also irreversibly bind to EC and kill to them in a synergistic manner. Figure 4 shows that EC preexposed to sublytic concentrations of PLC (a representative membrane-damaging agent) ~,nd then washed to remove unbound enzyme were still killed in a synergistic manner following the addition of H202. The same degree of killing was also ob~;erved if PLC and GO were simultaneously present throughout the incubation period. Similarly, cells incubated either with PLAz or with SLS (both highly hemolytic and cytolytic) and then washed and exposed to GO were also killed in a synergistic manner (not shown), suggesting that these membrane-active agents bound to the membrane and continued to exert their synergistic action with H202. Experiments performed with PLA2, however, necessitated the additio~ of fatty acid-free albumin to remove the cleaved fatty acid from the membranes of the EC. Experiments on the combined effect of LL and GO on EC killing (see Figure 12 below) show(~ that cells exposed to LL for 60 rain, followed by a 4 . The combined effect of PLC and GO on chromium release from EC. Monolayers of EC were treated for 30 min at 37~ with increasing concentrations of PLC. Some of the monolayers were washed to remove unbound PLC (*). GO (0.2 units/m1) was then added to all the wells, and the release of radioactivity was determined after a further incubation for 60 min. Note that EC, exposed to PLC and washed, were killed to the same degree as cells incubated with mixtures of PLC and GO, suggesting tha~: PLC firmly bound to EC and synergized with H202. The data are the averages of two experiments.
wash to remove unbound agent and by the addition of GO, were also killed but to a much lower degree (about 25 % release of chromium), suggesting that LL must be simultaneously present with H202 to exert its maximal toxic effects (see also Figure 14 below).
EC treated either by mixtures of PLC and peroxide or by SLS and peroxide developed, within 15-30 min, large blebs (pseudopodlike structures), usually in one pole of the cell. Many of these structures were later found as free-floating lipid like droplets (liposomes?). These morphological changes were essentially similar to those described either in tumor cells (16) or in epithelial cells exposed to similar agonists (21) . It is of interest that detachment of the liposomelike structures never occurred following exposure of EC either to SLS, PLC, or peroxide alone.
Combined Effects of LTA, Anti-LTA, and 11202 on EC. Previous studies have shown that target cells that had been sensitized by LTA derived from group A streptococci were killed following the addition of anti-LTA antibodies + complement (31) (32) (33) . In other studies, we have shown that human PMNs sensitized by LTA and then treated by anti-LTA globulin generated superoxide, H202, and chemiluminescence and released a variety of lysosomal enzymes (19) . The possibility that the presence of LTA-anti-LTA complexes on the surface of EC might render them more susceptible to the killing effects of H202 was investigated. Monolayers of EC were exposed to LTA (10-100 tzg/ml) for 30 min to allow cell binding. While LTA-coated EC exposed either to GO or to anti-LTA IgG (200/~g protein/ml) were not injured, a very marked release of radioactivity (50-60% of total) occurred when the LTA-sensitized EC were exposed to mixtures of anti-LTA-IgG and GO. Under similar conditions, nonimmune rabbit IgG (500 #g protein/ml) failed to cause such an effect. Paradoxically, however, and unexpectedly, EC incubated for 2 h with mixtures of anti-LTA IgG and H202 were also killed (50-60% chromium release). The possibility that the cytolytic effect observed was due to the presence in the anti-LTA IgG of antibodies cross-reacting with some epitopes present on the surface of EC was considered. Cross-reactivity between microbial antigens and those present in mammalian cells has been extensively studied (see Discussion). To address this point, we incubated the anti-streptococcal IgG (1 mg protein/ml) with streptococci (1 ml of a 10.OD at 550) for 2 h at 37~ and for an additional 24 h at 4~ to adsorb potential cross-reactive antibodies. The streptococci were then removed by high-speed centrifugation, and the supernatant fluid was employed to kill EC in the presence of GO. We found that the adsorbed IgG lost 60-70 % of its cytotoxicity when combined with sublytic amounts of GO-generated H202.
In other experiments we first exposed EC to anti-LTA IgG (1 mg protein/ml) for 2 h, then washed the cells and treated them with sublytic amounts of peroxide. A significant cytolytic reaction (25-35 % net chromium release) was also observed. These experiments suggested that we might be dealing with a novel phenomenon that noncytotoxic antibodies, which might recognize surface components of EC, became 0ytolytic in the presence of H202 (see Discussion).
Modulc!tion of EC Killing by Various Agents
To further study the mechanisms by which combinations among oxidants, membrane-damaging agents, and proteinases kill EC and release membrane lipids from these cells (see below), we tested the modulating effects o~f serum proteins, certain metabolic inhibitors, an agent affecting intracellular calcium, an analog of G-proteins, a transition metal chelator, a cytokine, and an agent that coats and denatures cell surfaces (see below).
EC were preincubated with the various agents for various times and then challenged either with GO-generated H202 alone or with combinations of peroxide and membrane-damaging agents. . Effect of 6-deoxyglucose on killing of endothelial cells by mixtures of H202 with histone or SLS. EC were exposed for 3 h at 37~ either to 5 mg/ml 6-deoxyglucose (EC-DEOXY) or to medium alone. The cells were then treated with increasing amounts either of histone or streptolysin S (SLS) and in the absence or presence of glucose oxidase (0.2 units/ml). Sixty minutes later, the release of chromium from the cells was determined. Note that while neither GO-generated hydrogen peroxide SLS, nor histone significantly enhanced the killing of deoxyglucose-treated (DEOXY) cells, combinations of GO + SLS or GO +histone were highly cytolytic for the deoxyglucosetreated cells, The data are the averages of two experiments.
Effect of 6-Deoxyglucose and
and subtoxic amounts of either PLC or of SLS. Our results, however, differ from those showing that 6-deoxyglucose inhibited cell killing by defensins (34, 35) . It is also of interest that EC that had been preincubated with 6-deoxyglucose did not possess diminished capacities to scavenge H202 (not shown), suggesting that the antimetabolite probably did not diminish their cell-associated catalase or glutathione peroxidase.
Effect of GTPTS. Killing of EC by mixtures of poly-L-arginine (PARG)
and hydrogen peroxide ( Figure 2B ) was unaffected by pretreatment with GTPTS. This agent was found to inhibit killing of targets by PARG (36), presumably because this polycation interacted with G-proteins. The possible reason for the observations made by Elferink and Deirkauf (36) might be due to the binding of GTP3~S (an anion) by PARG (a distinct polycation) but probably not to interference with G-proteins.
Effect of Deferoxamine. The possibility that EC killing by mixtures of
H202 and the various membrane-damaging agents involved the generation of hydroxyl radical via the metal-mediated Haber-Weiss reaction (37), which could have killed the cells, was tested by the addition of deferoxamine (3 mM) to the reaction mixtures. No modulation of cell killing was observed, however, suggesting that OH radical might not be involved in EC killing in this model (37) .
Effect of TNF. It is well accepted that TNF is cytotoxic for a variety of
mammalian cells (38, 39) . The possibility that subtoxic amounts of TNF might act synergistically with H202 to kill EC was also investigated. TNF (up to 500 ~g/ml), which failed to cause any substantial release of chromium from EC after 2 h of incubation, synergized with H202 only to a very small extent (6 _ 2.0% chromium release, N = 3). It is of interest in this respect that the toxicity of TNF to target cells was found to be greatly reduced in the presence of H202 (40) .
Effect of Hypochlorous Acid. HC10 is a potent cytotoxic oxidant that is generated by activated PMNs (41). We, however, found that HC10 at a wide range of subtoxic concentrations did not modulate EC killing induced by mixtures of H202 with either PLC or with SLS.
Effect of Trifluopromazin (TFP).
TFP was found to modulate superoxide generation induced in PMNs (42, 43) . The possibility that interference with calmodulin (44) might also alter the susceptibility of EC to killing by mixtures of hydrogen peroxide and membrane-damaging agents was therefore investigated. 6 . Effect of triflupromazine (TFP) on killing EC in the presence of PLC and GO. EC monolayers were exposed for t20 rain at 37 ~ to increasing concentrations of TFP. The cells were then further exposed for an additional 60 minutes either to GO (0.2 units/ml), PLC (0.05 units/ml), or mixtures of PLC and GO. The data are the averages of three experiments.
extracts of black tea (1 g of tea brewed with 10 ml of boiling water), followed by a cell wash, caused 95 % inhibition of chromium release from EC exposed to mixtures of H202 either with PLC or with SLS (not shown). The same amounts either of tannic acid or tea also very markedly inhibited lysis of human RBC induced either by SLS or by PLC. Our findings suggest, therefore, that coating by tannic acid, which alters cell surfaces, might also affect other cell types (e.g., epithelial cells in the gut), protecting them against microbial toxins and leukocyte hydrolases.
Effect of Serum Proteins and Inhibitors.
The possibility that serum proteins might modulate EC killing by mixtures of oxidants and membrane-damaging agents was also investigated. Figures 7 and 8 show that larger amounts of either CETAB or histone were necessary to kill EC in the presence of H202 and 10% fetal calf serum. Inhibition by serum proteins might be due to albumin (a polyanion), which bound the cationic agents employed. On the other hand, serum at the same conce, ntration caused only about 25 % inhibition of EC killing induced by mixtures of H202 with either SLS or PLC (not shown). In another EC model we also inw~stigated the effect of higher amounts of serum on EC killing induced by a "super killer cocktail" of agonists (H202, HC10, histone, PLC, LL, and trypsin) that might mimic the mixture of agents likely to be generated by PMNs in inflamed sites. Such a cocktail had a killing capacity of at least five times that reduced by mixtures of peroxide with any of the single agonists tested. Figure 9 shows that even in the presence of 40% serum, no substantial inhibition of EC killing by the superkiller cocktail occurred unless a mixture of antagonists (catalase, taurine, heparin, SBTI, and phosphatidylcholine--an inhibitor of PLC and LL) was also added. These results suggest that cell injury in inflammatory sites might also be inhibited by such a mixture of antagonists administered either systemically or injected locally.
Release of Arachidonic Acid and Metabolites from EC
It is well established that an alteration in the integrity of cell membranes occurs when certain microbial products (hemolysins, phospholipases, pore-forming toxins) as well as snake and bee toxins interact with cells (2, 3, 21) . The activation of membrane-associated PLA2 by a variety of agonists might also result in the release of AA and its metabolites, as well as in the formation of membrane-associated lyso compounds (20) . To study whether the killing of EC by the synergistic effects of oxidants and membrane-damaging agents was also accompanied by the solubilization of AA and certain of its metabolites, we employed parallel tissue culture plates labeled either with chromium or tritiated AA. We treated the cells with a variety of agonists and determined the solubilization of chromium and of AA. Figure 10 shows the time course of chromium and of AA release from EC treated by combinations of H20/, PLC, and trypsin. While maximal killing of EC was induced by mixtures of peroxide and PLC, maximal solubilization of AA necessitated the additional presence of the proteinase. Similar effects were also found when elastase replaced trypsin (not shown). A very marked decrease in AA release was observed when either catalase, DMTU, or SBTI were included FCS (%) Fig. 9 . Effect of serum and inhibitors on killing of EC induced by a cocktail of agonists. EC were exposed for 90 min at 37~ to a cocktail comprised of GO (0.2 units/ml), histone (100 /zg/ml), phospholipase C (0.05 units/:nl), hypochlorous acid (10 4 M), lysolecithin (5 #g/m1), and trypsin (50 #g/ml) and in the presence of increasing concentrations of fetal calf serum. Note that even 40% serum failed to significantly inhibit killing of EC by this cocktail of agonists. On the other hand, a cocktail of inhibitors comprised of catalase (100 units/ml) soybean trypsin inhibitor (200 #g/ml), phosphatidylcholine (500 #g/ml), taurine (1 raM), and heparin (85 units/ml) markedly depressed cell killing in the presence of 10-40% serum. The data are the averages of two experiments.
in the reaction mixtures (not shown). Figure 11 shows the dependency on trypsin concentration of AA release in the presence of PLC and H202, again showing that all three agents had to be present simultaneously to achieve maximal solubilization of AA. and trypsin also released synergistic amounts of PGE 2 ( Figure 13 ) and mixtures of H202 either with PLC or with SLS and with trypsin released synergistic amounts of 6-keto-PGF (Figure 14) . On the other hand, none of the mixtures of agonists tested had file capacity to solubilize significant amounts of thromboxane B2 (not shown). 
Modulation of AA Release by Various Agents
Effect of Cationic Agents. Cationic agents (histone, PARG, CETAB, chlorhexidine) that synergized with H202 kill EC (Figures 1, 2 ) but failed to synergize with H202 to solubilize AA (not shown). It was, therefore, of interest to test the possibility that cationic agents might interfere with AA release from EC. Cell monolayers were exposed for 15 min to subtoxic concentrations either of PARG (5/xg/ml) or CETAB (5/z/ml) and then washed. The cells were then exposed to mixtures of H202 with PLC and trypsin (see Figure 10 ). We invariably found that preexposure to cationic agents depressed AA release by 75-100% (not shown). These results suggest that cationic agents released either by leukocytes or from disintegrating cells in vivo might perhaps modulate the release of AA and its metabolites.
Effect of HClO. HC10 (at 10 -4 M), which failed to synergize with H202 to kill EC, caused 75% inhibition of AA release when mixed with peroxide, PLC, and trypsin (not shown).
Effect of Tannic Acid. Tannic Effect of Quinacrine. The possibility that treatment by agonists that might activate a membrane-associated PLA 2 might also release AA was studied by the inclusion of quinacrine (a PLA 2 inhibitor) in the reaction mixtures. It was found that at 10 -4 M quinacrine depressed AA release from EC treated with mixtures of peroxide, PLC, and trypsin by about 50% (not shown). Paradoxically, however, quinacrine at this concentration acted synergistically with H202 to kill EC (not shown).
DISCUSSION
The present experimental model further examines the assumption that cellular injury that accompanies infectious and inflammatory processes might be due, in part, to the synergistic action among oxidants and hydrolases secreted either by activated leukocytes, released by disintegrating host cells, or elaborated by microorganisms (17, 18, 21) . Such agents alter cell viability (14, 15, 17, 18, 21) and are also instrumental in releasing membrane-associated arachidonic acid (AA) and some of its metabolites, which might further modulate the inflammatory processes.
Our studies suggest that the simultaneous presence of H202 and several of the membrane-damaging agents is absolutely essential to secure maximal killing of the targets (Figures ~L-3) . Histone, SLS, and PLC, at subtoxic concentrations, which bind to EC membranes and resist washing, can nevertheless continue to synergize with H202 to release radiolabeled chromium (Table 1, Figures 4 and   12 ), presumably because of their ability to alter membrane permeability and thus to prime the cells for a further oxidant insult (3, 17, 21, 34, 35) .
Since H202 does aot irreversibly bind to membranes (Tables 1 and 2 ), the ability to bind GO (an HzOz-generating enzyme) to mammalian cells by cationization with PHSTD (Table 2 ) might serve as a useful tool to enhance cell killing in vivo (i.e., tumor cells). Our preliminary findings on the high toxicity of cationized OG in tl~e rat lung model is one such an example (29) .
The findings that chlorhexidine, a potent cationic antiseptic widely used in dentistry to treat oral lesions, also acts synergistically with H202 to kill EC ( Figure 2B ) suggest that this agent should either not be applied to severely inflamed tissue or used in the oral cavities of patients undergoing irradiation of the head and neck for treatment of malignancies. The same might be also true for the antibiotic polymyxin B (Figure 2A) .
The ability of lysozyme, a distinct bacteriolytic polycation (48) to synergize with hydrogen peroxide to kill EC is also important, as inflammatory exudates might contain large amounts of this enzyme, which, like other polycations present in inflammatory sites (4, 6, 28) , might also amplify oxidant damage, espe-cially in an acidic milieu that increases the cationization of the enzyme. Thus, such cationic proteins might also synergize with oxidants, with phospholipases, and with microbial hemolysins to kill target ceils, as shown in the present study. It might also be speculated that since synergism between SLS and oxidants kills EC, other microbial hemolysins and perhaps also the attack complex of complement (13) might also synergize with oxidants and with proteinase to enhance cellular damage.
The findings that the synergistic killing effect induced by oxidants and membrane-active agents was totally inhibited either by scavengers of H202 (catalase, DMTU, Mn2+), by polyanions, by proteinase inhibitors, or by phospholipids ( Figure 9 ) also suggest that in in vivo models the administration of adequate "cocktails" of antagonists might ameliorate the toxic effects exerted by such potentially synergizing agents ( Figure 9 ) (21, 29) .
The ability of 6-deoxyglucose ( Figure 5 ) and puromycin (not shown) to markedly enhance the susceptibility of EC to the synergistic killing effects of oxidants with PLC or histone but not to H202 alone suggests that the enhanced susceptibility was presumably caused by altering complex metabolic pathways that might affect the ability of the cells to repair damage caused by H202 (49) . The interference with calcium balance induced by the calmodulin antagonist TFP ( Figure 6 ) (42-44) also markedly enhanced the susceptibility of EC to killing by combinations of H202 with membrane-damaging agents. On the other hand, neither GTP3'S (a putative antagonist of G proteins), shown to inhibit target cell killing by PARG (36) , nor TNF, shown to possess a cytotoxic activity (38, 39) , had any appreciable modulating effects on EC killing. In this respect it is of interest that H202 diminished the toxic effects of TNF on targets (40) , also suggesting that a complex interplay among cytokines, oxidants, and proteinases might exist in inflamed sites.
The findings that both tannic acid and extracts of tea, known to be rich in this acid, very markedly inhibited both the killing of EC induced by mixtures of H202 and PLC or SLS, and the hemolysis of RBC caused either by PLC or by SLS, is noteworthy. It further suggests that other cell types, e.g., epithelial cells in the gastrointestinal tract, might also be shielded by tannic acid against toxins elaborated by gram-negative microorganisms as well as against leukocytederived oxidants and hydrolases (45) (46) (47) .
The inability of deferoxamine to inhibit EC killing induced by the various "cocktails" suggests that the OH radical that could have been generated might not be involved in our model (37) . Experiments to localize a possible presence of the OH radical by spin-trapping might resolve this question.
The findings that rabbit anti-streptococcal IgG acted synergistically with H202 to kill EC and the ability of streptococci to adsorb the bulk of the active agent present in IgG that synergized with hydrogen peroxide to kill EC are intriguing. It points, however, to the possible presence in the anti-streptococcal serum of antibodies cross-reacting with EC (50) (51) (52) . If, indeed, cytotoxicity was caused by such cross-reactive antibodies, it might be the first report to show that such potential cytotoxic antibodies might be amplified by a peroxide. It is of interest, however, that anti-streptococcal antibodies cross-reactive with heart or kidney have never been shown to possess cytotoxic activities either in vitro or in vivo (50-52) unless an additional insult, i.e., treatment with isoproteranol was given (53) (also a synergistic action?).
A very important observation described in our study is that, whereas two agents (H202 combined with a membrane-damaging agent) were sufficient to cause maximal cell death as measured by the chromium release assay ( Figures  1-6, 10A, and 12A) , a significant solubilization of AA and several of its metabolites necessitated the additional presence of a proteinase ( Figures 10A, 12A , 13, and 14). It suggests that potent cyclooxygenase products, capable of modulating the inflammatou~ responses, can also be released from dead cells abundantly present in inflamed sites. It is also suggested that both the measurements of lipid and chromium release from cells yield better information on the mechanism of cell damage. The findings that none of the agonists tested were capable of releasing significant amounts of thromboxane B2 is not understood and further studies on this issue are warranted (55) .
The role of H202 as a low-level releaser of arachidonic acid from a variety of mammalian cells was recently reported (25, (54) (55) (56) . One study (25) showed that even millimolar concentrations of peroxide failed to release any substantial amounts of labeled AA from macrophages. Another study (55) showed that H202 was capable of solubilizing some 6-keto-PGFt and thromboxane B2 from targets. This was strongly inhibited by quinacrine (a PLA2 inhibitor). Our study, however, is the first report showing that a proteinase is necessary for the solubilization of large amounts of AA from EC treated by mixtures of H202 with cytolytic agents (PLC, LL, SLS).
The cardinal rote played by proteinases in AA release, as shown in the in vitro model, implies that a similar phenomenon might also occur in inflammatory sites known to contain all the necessary agonists capable of causing cell death and probably also the release of membrane lipids possessing potent pharmacological properties.
However, not all the membrane-active agents tested were capable of synergizing with H202 and with a proteinase to release AA from EC. Cationic agents, which, together with H::O2, killed EC (Figures 1-3 ), failed to release any appreciable amounts of AA. Furthermore, cationic agents (PARG, chlorhexidine, CETAB) very markedly inhibited the release of AA from the injured cells induced by mixtures of oxidants with membrane-damaging agents and with a proteinase. Inhibition by cationic agents might be due to their ability to interact electrostatically with anionic sites (sialic acid, acid phospholipids) present on cell surfaces. They might also inactivate membrane-associated enzymes that partic-ipate in lipid release (21) . Other potent inhibitors of AA release from EC are quinacrine (an inhibitor of PLA2), HC10, which might oxidize surface components, and tannic acid and tea extracts, which are known to denature proteins and which were also shown to inhibit lysis of RBC by PLC and SLS.
Taken together, our findings suggest that sublethal injuries induced in mammalian cells, either by oxidants that interfere with cell metabolism and inhibit repair of minor cellular damage (57) (58) (59) (60) (61) or by membrane-damaging agents (21) , can be greatly amplified by mixtures of the two types of agonists. Cellular destruction might further be augmented if proteinases and other proinflammatory agents are also present. The detailed mechanisms by which oxidants, membranedamaging agents, and proteinases injure and kill mammalian cells has recently been reviewed in detail (12, 21, (57) (58) (59) (60) (61) (62) , and this issue is beyond the scope of the present communication.
Our studies with the EC model in culture might open new avenues to elucidate the mechanisms of tissue destruction in vivo. The data in Figure 9 indicate that serum proteins might not hinder the synergistic effects of a mixture of agonists likely to be present in inflamed sites. Furthermore, adequate cocktails of antagonists might prove beneficial for the prevention of the synergistic killing and lipid-releasing capacities of leukocyte products. Such cocktails of antagonists might also prove beneficial in preventing tissue damage in ischemia and reperfusion (62) as well as in a variety of other inflammatory conditions and their sequelae.
Finally, current studies from our laboratories (submitted for publication) have also shown that EC exposed to subtoxic amounts of a variety of pesticides (lindane, parathion, malathion) were also killed in a synergistic manner by subtoxic mixtures of oxidants and membrane-damaging agents. These agents also released substantial amounts of AA. It is suggested, therefore, that the synergy phenomenon described in our communications (17, 18, 21) is probably universal.
